- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Pfizer’s 20vPnC boosts immune response in pneumococcal disease trial

The vaccine candidate showed positive safety results to 20 S. pneumoniae serotypes in adults and infants. Credit: Angelo Esslinger on Pixabay.